|
SearchBladder Cancer: Free Medical and Health Information on Bladder Cancer Research and TreatmentBladder Cancer
Search within these results:
Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating un
Bladder cancer stem (initiating) cell has not been isolated now, and no one verified its persistence experimentally.
Tianjin, China China Curcumin is the active component of tumeric, and this polyphenolic compound has been extensively investigated as an anticancer drug that modulates multiple pathways and genes.
College Station, TX 77843-4466 USA OBJECTIVE: To describe clinical needs in non-muscle invasive bladder cancer (NMIBC) and review the potential of apaziquone in this respect.
PO Box 9101, 6500 H.B Nijmegen
The Netherlands Evolution of intravesical immunotherapy for bladder cancer: mycobacterial cell wall preparation as a
BACKGROUND: The intra-cavitary administration of antineoplastic agents for the treatment of non-invasive bladder cancer has met with variable results.
62 Barrie Street
Kingston, Ontario Canada PURPOSE: We performed a critical analysis of the results of radical cystectomy for invasive bladder carcinoma treated at 1 center.
Mansoura, Egypt Egypt Matrix metalloproteinase-9 (MMP-9) immunoreactive protein in urinary bladder cancer: a marker of fav
BACKGROUND: [corrected] The purpose of this study was to explore whether changes in matrix metalloproteinase-9 (MMP-9) are involved in the progression of urinary bladder cancer and whether they have any prognostic value.
Oulu, Finland Finland The predictors of local recurrence after radical cystectomy in patients with invasive bladder cancer
OBJECTIVES: To examine the association between local recurrence and distant metastasis or disease-specific survival and identify independent factor predictors for local recurrence.
Tokyo, Japan 160-8582 Japan The inhibition of tumorigenesis by tea extracts and tea polyphenols has been demonstrated in different animal models, including those for cancer of the skin, lung, oral cavity, esophagus, stomach, small intestine, colon, bladder, liver, pancrease, prostate, and mammary glands
164 Frelinghuysen Road
Piscataway, NJ 08854-8020 USA Identification of bladder cancer patients at risk for recurrence or progression: an immunohistochemi
Despite similarities in tumor stage and grade the individual outcome of bladder cancer patients is not predictable.
Germany |
PartnersLinksApproved By
|